Abstract
Here, we report a case of lung adenocarcinoma resistant to crizotinib harboring KRAS mutation and the echinoderm microtubule-associated protein-like 4 ( EML4 )-anaplastic lymphoma kinase ( ALK ) fusion gene. Our case suggests that KRAS mutation in addition to EML4-ALK fusion gene may cause the resistance to crizotinib. J Med Cases. 2014;5(12):631-633 doi: http://dx.doi.org/10.14740/jmc1985w
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
